» Articles » PMID: 16639472

A Novel, Simple Scale for Assessing the Symptom Severity of Atrial Fibrillation at the Bedside: the CCS-SAF Scale

Overview
Journal Can J Cardiol
Publisher Elsevier
Date 2006 Apr 28
PMID 16639472
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The severity of symptoms caused by atrial fibrillation (AF) is extremely variable. Quantifying the effect of AF on patient well-being is important but there is no simple, commonly accepted measure of the effect of AF on quality of life (QoL). Current QoL measures are cumbersome and impractical for clinical use.

Objective: To create a simple, concise and readily usable AF severity score to facilitate treatment decisions and physician communication.

Methods: The Canadian Cardiovascular Society (CCS) Severity of Atrial Fibrillation (SAF) Scale is analogous to the CCS Angina Functional Class. The CCS-SAF score is determined using three steps: documentation of possible AF-related symptoms (palpitations, dyspnea, dizziness/syncope, chest pain, weakness/fatigue); determination of symptom-rhythm correlation; and assessment of the effect of these symptoms on patient daily function and QoL. CCS-SAF scores range from 0 (asymptomatic) to 4 (severe impact of symptoms on QoL and activities of daily living). Patients are also categorized by type of AF (paroxysmal versus persistent/permanent). The CCS-SAF Scale will be validated using accepted measures of patient-perceived severity of symptoms and impairment of QoL and will require 'field testing' to ensure its applicability and reproducibility in the clinical setting.

Conclusions: This type of symptom severity scale, like the New York Heart Association Functional Class for heart failure symptoms and the CCS Functional Class for angina symptoms, trades precision and comprehensiveness for simplicity and ease of use at the bedside. A common language to quantify AF severity may help to improve patient care.

Citing Articles

Complexity AF score as a novel marker of atrial fibrillation instability.

Lee J, Brower A, Roukoz H, Tolkacheva E Sci Rep. 2024; 14(1):27833.

PMID: 39537673 PMC: 11561269. DOI: 10.1038/s41598-024-76611-7.


ANMCO-SIMEU consensus document: appropriate management of atrial fibrillation in the emergency department.

Caldarola P, Iaco F, Pugliese F, De Luca L, Fabbri A, Riccio C Eur Heart J Suppl. 2023; 25(Suppl D):D255-D277.

PMID: 37213798 PMC: 10194824. DOI: 10.1093/eurheartjsupp/suad110.


JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.

Ono K, Iwasaki Y, Akao M, Ikeda T, Ishii K, Inden Y J Arrhythm. 2022; 38(6):833-973.

PMID: 36524037 PMC: 9745564. DOI: 10.1002/joa3.12714.


'Out of sync': a qualitative investigation of patients' experiences of atrial fibrillation and perceptions of weight management.

Bates R, Bailey C, Topping A BMJ Open. 2022; 12(11):e065995.

PMID: 36343999 PMC: 9644348. DOI: 10.1136/bmjopen-2022-065995.


Clinical Outcomes of Rhythm Control Strategies for Asymptomatic Atrial Fibrillation According to the Quality-of-Life Score: The CODE-AF (Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation) Registry.

Kim J, Park H, Park H, Choi E, Park J, Kim J J Am Heart Assoc. 2022; 11(18):e025956.

PMID: 36073646 PMC: 9683675. DOI: 10.1161/JAHA.122.025956.


References
1.
Page R, WILKINSON W, Clair W, McCarthy E, Pritchett E . Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 1994; 89(1):224-7. DOI: 10.1161/01.cir.89.1.224. View

2.
Jenkins L, Brodsky M, Schron E, Chung M, Rocco Jr T, Lader E . Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005; 149(1):112-20. DOI: 10.1016/j.ahj.2004.03.065. View

3.
Dorian P, Paquette M, Newman D, Green M, Connolly S, Talajic M . Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J. 2002; 143(6):984-90. DOI: 10.1067/mhj.2002.122518. View

4.
Fuster V, Ryden L, Asinger R, Cannom D, Crijns H, Frye R . ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice.... Eur Heart J. 2001; 22(20):1852-923. DOI: 10.1053/euhj.2001.2983. View

5.
Paquette M, Roy D, Talajic M, Newman D, Couturier A, Yang C . Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am J Cardiol. 2000; 86(7):764-8. DOI: 10.1016/s0002-9149(00)01077-8. View